Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 3
1986 2
1988 3
1990 3
1992 1
1993 1
1995 3
1996 2
1997 5
1998 1
1999 6
2000 9
2001 7
2002 7
2003 5
2004 8
2005 11
2006 8
2007 9
2008 8
2009 8
2010 7
2011 7
2012 11
2013 13
2014 13
2015 16
2016 18
2017 18
2018 14
2019 10
2020 22
2021 8
2022 9
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

257 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Bone Erdheim-Chester Disease"
Page 1
Histiocytic disorders.
McClain KL, Bigenwald C, Collin M, Haroche J, Marsh RA, Merad M, Picarsic J, Ribeiro KB, Allen CE. McClain KL, et al. Nat Rev Dis Primers. 2021 Oct 7;7(1):73. doi: 10.1038/s41572-021-00307-9. Nat Rev Dis Primers. 2021. PMID: 34620874 Free PMC article. Review.
These cells may arise from the embryonic yolk sac, fetal liver or postnatal bone marrow. Prior classification schemes align disease designation with terminal phenotype: for example, Langerhans cell histiocytosis (LCH) shares CD207(+) antigen with physiological epide …
These cells may arise from the embryonic yolk sac, fetal liver or postnatal bone marrow. Prior classification schemes align diseas …
Erdheim-Chester disease.
Haroche J, Cohen-Aubart F, Amoura Z. Haroche J, et al. Blood. 2020 Apr 16;135(16):1311-1318. doi: 10.1182/blood.2019002766. Blood. 2020. PMID: 32107533 Free article. Review.
Erdheim-Chester disease (ECD) is characterized by the infiltration of tissues by foamy CD68+CD1a- histiocytes, with 1500 known cases since 1930. ...Targeted therapies have an overall, robust, and reproducible efficacy in ECD, with no acquired resistance to da …
Erdheim-Chester disease (ECD) is characterized by the infiltration of tissues by foamy CD68+CD1a- histiocytes, with 150 …
Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era.
Goyal G, Heaney ML, Collin M, Cohen-Aubart F, Vaglio A, Durham BH, Hershkovitz-Rokah O, Girschikofsky M, Jacobsen ED, Toyama K, Goodman AM, Hendrie P, Cao XX, Estrada-Veras JI, Shpilberg O, Abdo A, Kurokawa M, Dagna L, McClain KL, Mazor RD, Picarsic J, Janku F, Go RS, Haroche J, Diamond EL. Goyal G, et al. Blood. 2020 May 28;135(22):1929-1945. doi: 10.1182/blood.2019003507. Blood. 2020. PMID: 32187362 Free article. Review.
Erdheim-Chester disease (ECD) is a rare histiocytosis that was recently recognized as a neoplastic disorder owing to the discovery of recurrent activating MAPK (RAS-RAF-MEK-ERK) pathway mutations. ...Most patients with ECD require treatment, except for a mino …
Erdheim-Chester disease (ECD) is a rare histiocytosis that was recently recognized as a neoplastic disorder owing to th …
How I Diagnose Rosai-Dorfman Disease.
Ravindran A, Rech KL. Ravindran A, et al. Am J Clin Pathol. 2023 Jul 5;160(1):1-10. doi: 10.1093/ajcp/aqad047. Am J Clin Pathol. 2023. PMID: 37167084
OBJECTIVES: Rosai-Dorfman disease (RDD) is one of 3 major types of histiocytosis, along with Erdheim-Chester disease and Langerhans cell histiocytosis. ...METHODS: We discuss the diagnosis of RDD using 2 illustrative cases, interpretative challenges, a …
OBJECTIVES: Rosai-Dorfman disease (RDD) is one of 3 major types of histiocytosis, along with Erdheim-Chester disease …
Erdheim-Chester disease.
Starkebaum G, Hendrie P. Starkebaum G, et al. Best Pract Res Clin Rheumatol. 2020 Aug;34(4):101510. doi: 10.1016/j.berh.2020.101510. Epub 2020 Apr 15. Best Pract Res Clin Rheumatol. 2020. PMID: 32305313 Review.
Erdheim-Chester disease (ECD) is a rare but increasingly recognized multi-system disorder. ...Of note, ECD can now be defined as a clonal myeloid disorder due to mutations which activate mitogen-activated protein kinase (MAPK) pathways and where an inflammato …
Erdheim-Chester disease (ECD) is a rare but increasingly recognized multi-system disorder. ...Of note, ECD can now be d …
Highlights of the Management of Adult Histiocytic Disorders: Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Rosai-Dorfman Disease, and Hemophagocytic Lymphohistiocytosis.
Salama HA, Jazieh AR, Alhejazi AY, Absi A, Alshieban S, Alzahrani M, Alaskar A, Gmati G, Damlaj M, Abuelgasim KA, Alghamdi A, Alahmari B, Almugairi A, Alzahrani H, Bazarbachi A, Musa MOH, Goyal G. Salama HA, et al. Clin Lymphoma Myeloma Leuk. 2021 Jan;21(1):e66-e75. doi: 10.1016/j.clml.2020.08.007. Epub 2020 Aug 18. Clin Lymphoma Myeloma Leuk. 2021. PMID: 32943371 Free PMC article. Review.
In an attempt to improve the understanding of the clinical features and management of common adult histiocytic disorders (Langerhans cell histiocytosis, Erdheim-Chester disease, Rosai-Dorfman disease, and hemophagocytic lymphohistiocytosis), we created …
In an attempt to improve the understanding of the clinical features and management of common adult histiocytic disorders (Langerhans cell hi …
Erdheim-Chester disease.
Akkara Veetil BM, Luthra H. Akkara Veetil BM, et al. Clin Rheumatol. 2011 Mar;30(3):397-8. doi: 10.1007/s10067-010-1595-z. Epub 2010 Oct 15. Clin Rheumatol. 2011. PMID: 20949296
Erdheim-Chester disease is characterized by long bone pain and symmetric sclerosis of the diametaphyseal portions of the long bones. It is an important differential diagnosis of sclerotic disease of the bones....
Erdheim-Chester disease is characterized by long bone pain and symmetric sclerosis of the diametaphyseal portion …
Erdheim-Chester disease.
Haroche J, Arnaud L, Cohen-Aubart F, Hervier B, Charlotte F, Emile JF, Amoura Z. Haroche J, et al. Curr Rheumatol Rep. 2014 Apr;16(4):412. doi: 10.1007/s11926-014-0412-0. Curr Rheumatol Rep. 2014. PMID: 24532298 Review.
Erdheim-Chester disease (ECD) is a rare (approximately 500 known cases worldwide), non-inherited, non-Langerhans form of histiocytosis of unknown origin, first described in 1930. ...Diagnosis of ECD involves the analysis of histiocytes in tissue biopsies: the …
Erdheim-Chester disease (ECD) is a rare (approximately 500 known cases worldwide), non-inherited, non-Langerhans form o …
Erdheim-Chester disease: a rapidly evolving disease model.
Pegoraro F, Papo M, Maniscalco V, Charlotte F, Haroche J, Vaglio A. Pegoraro F, et al. Leukemia. 2020 Nov;34(11):2840-2857. doi: 10.1038/s41375-020-0944-4. Epub 2020 Jun 26. Leukemia. 2020. PMID: 32591646 Review.
Erdheim-Chester disease (ECD) is a rare non-Langerhans cell histiocytosis with a putative neoplastic and inflammatory nature. ...The clinical presentation of ECD is highly heterogeneous, ranging from smouldering unifocal forms to multiorgan life-threatening …
Erdheim-Chester disease (ECD) is a rare non-Langerhans cell histiocytosis with a putative neoplastic and inflammatory n …
Erdheim-Chester disease: characteristics and management.
Munoz J, Janku F, Cohen PR, Kurzrock R. Munoz J, et al. Mayo Clin Proc. 2014 Jul;89(7):985-96. doi: 10.1016/j.mayocp.2014.01.023. Epub 2014 May 9. Mayo Clin Proc. 2014. PMID: 24814521 Review.
Erdheim-Chester disease is a rare CD68(+), CD1a(-) non-Langerhans cell histiocytosis with multiorgan involvement. ...The present review details our approach to the management of patients with Erdheim-Chester disease....
Erdheim-Chester disease is a rare CD68(+), CD1a(-) non-Langerhans cell histiocytosis with multiorgan involvement. ...Th …
257 results